Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

GluR-5 Inhibitors

GluR-5 Inhibitors are a class of chemicals designed to selectively target the GluR-5 receptor, a subtype of the kainate family of ionotropic glutamate receptors. These inhibitors play a crucial role in modulating excitatory neurotransmission in the central nervous system, offering avenues for various neurological conditions. The GluR-5 receptor is involved in synaptic transmission and plasticity, and its dysregulation is implicated in conditions like epilepsy, neuropathic pain, and certain psychiatric disorders. The primary mechanism of action of GluR-5 inhibitors involves the blockade of glutamate binding to the receptor, thus impeding receptor activation and subsequent neuronal excitation. Some inhibitors, such as UBP310 and UBP302, are competitive antagonists, directly competing with glutamate for binding sites on the receptor. Others, like NS3763, function as non-competitive antagonists, altering receptor function without directly competing with glutamate. This variation in the mode of action allows for a more nuanced approach to modulating GluR-5 receptor activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Topiramate

97240-79-4sc-204350
sc-204350A
10 mg
50 mg
$107.00
$369.00
(1)

Topiramate acts as a selective modulator of the GluR5 receptor, engaging in specific hydrogen bonding interactions that stabilize its binding conformation. This interaction leads to a unique alteration in receptor dynamics, promoting a shift in ion permeability. The compound's affinity for the receptor is influenced by its stereochemistry, resulting in distinct kinetic profiles that affect the rate of receptor activation and desensitization, ultimately impacting synaptic plasticity.

UBP 310

902464-46-4sc-361389
sc-361389A
10 mg
50 mg
$169.00
$615.00
1
(0)

UBP310 is a potent and selective antagonist of the GluR-5 receptor. It acts by competitively inhibiting glutamate binding, thus reducing receptor activation and subsequent neuronal excitation.

UBP 296

745055-86-1sc-204366
sc-204366A
1 mg
10 mg
$190.00
$900.00
(0)

UBP 296 functions as a selective antagonist of the GluR5 receptor, exhibiting unique electrostatic interactions that disrupt the receptor's conformational stability. This compound alters the receptor's ion channel kinetics, leading to a pronounced modulation of calcium influx. Its distinct molecular architecture allows for specific binding that influences downstream signaling pathways, thereby affecting neuronal excitability and synaptic transmission dynamics.